Actuate Therapeutics, Inc. (NASDAQ:ACTU) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and warrants Announced: about US$11M · US$0.71 a share · 1 warrant at US$0.45 for 60 months · Newbridge Securities Corporation Dealers: Newbridge Securities Corporation (lead) Use of proceeds: Working capital and general corporate purposes | Oct 27, 2026 |
| Public offering of common stock Closed: US$17.25M raised · US$7 a share · Lucid Capital Markets +1 Dealers: Lucid Capital Markets (lead), Titan Partners Group, a division of American Capital Partners Use of proceeds: Working capital and general corporate purposes | Sep 11, 2025 |